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A new medium for the isolation of Pseudomonas cepacia from respiratory tract secretions of patients with
cystic fibrosis (CF) is described. This medium consists of inorganic salts, 0.5% pyruvate, and 0.1% proteose
peptone as nutritive components and 0.0001% crystal violet, 0.15% bile salts, 100 ,ug of ticarcillin per ml, and
300 U of polymyxin B per ml as selective agents. The medium, designated PC medium, supported superior
growth of 38 of 50 stock isolates of P. cepacia after 48 h of incubation when compared with MacConkey agar
(O of 50). The medium completely inhibited the growth of 112 of 124 stock isolates of organisms commonly
found in respiratory secretions of CF patients. Cultures were made on PC medium with respiratory secretions
of 169 CF patients. P. cepacia was recovered from 35 patients with isolates on PC medium but from only 21
patients with isolates on MacConkey agar. Of 221 other potentially pathogenic isolates found in these
specimens, only six (two Pseudomonas aeruginosa isolates, two molds, one yeast, and one Serratia marcescens
isolate) grew on PC medium. PC medium should facilitate the recovery of P. cepacia from CF patients.
Recent studies have suggested that Pseudomonas cepacia
may be emerging as an important pulmonary pathogen in
patients with cystic fibrosis (CF) (6, 8, 12). In a case-
controlled study, CF patients colonized with P. cepacia
were more frequently hospitalized and died earlier than
control CF patients (O. C. Tablan, T. L. Chorba, D. V.
Schidlow, K. A. Hardy, P. H. Gilligan, J. H. White, W. M.
Morgan, L. A. Carson, W. J. Martone, J. M. Jason, and
W. R. Jarvis, J. Pediatr., in press). Clinical experience
suggests that the emergence of this organism in the respira-
tory tree of older CF patients can be associated with rapid
deterioration in pulmonary status and death (6). Despite
these data, the role ofP. cepacia in pulmonary disease ofCF
patients remains unclear. One of the major problems in
determining the actual incidence of colonization by P.
cepacia in CF patients with severe pulmonary disease has
been difficulty in isolating this organism. Although P.
cepacia can survive and multiply in hostile environments
such as distilled water and disinfectants (2-4), it has been our
experience that it often grows more slowly on commonly
used laboratory media such as blood and MacConkey agar
than do other organisms, such as Pseudomonas aeruginosa,
Staphylococcus aureus, and Escherichia coli commonly
found in the respiratory tree of CF patients. We have also
observed that P. cepacia can be overgrown by these orga-
nisms on media commonly used for its isolation. We de-
signed an isolation medium for the recovery of P. cepacia,
designated PC medium, to enable investigators to isolate P.
cepacia more reliably from CF patients. PC medium is based
in part on a holding medium designed by one of us (B.T.D.)
for long-term maintenance of P. cepacia, other pseudo-
monads, and Enterobacteriaceae.
(This work was presented in part previously [P. H. Gil-
ligan and L. M. Bradshaw, Program Abstr. 24th Intersci.
* Corresponding author.
Conf. Antimicrob. Agents Chemother., abstr. no. 178,
1984].)
MATERIALS AND METHODS
PC medium formulation. DeCicco holding medium con-
tained, per liter, (NH4)2SO4, 1.0 g; MgSO4 * 7H20, 0.2 g;
Fe(NH4SO4)2 * 6H20, 0.01 g; phenol red, 0.02 g; and agar, 15
g, dissolved in 950 ml of 0.04 M potassium phosphate buffer
(pH 6.2). After being autoclaved at 121°C for 15 min and
cooled to 50°C, 50 ml of 10% pyruvic acid sodium salt was
added to the basal medium. The following additions to
DeCicco holding medium were necessary to ensure that PC
medium would support rapid growth of all strains of P.
cepacia while remaining sufficiently selective to inhibit the
growth of other organisms commonly found in the respira-
tory tree of CF patients. Before the medium was autoclaved,
0.1 ml of 1% crystal violet, 1.0 g of proteose peptone no. 3,
and 1.5 g of bile salts were added per liter of medium. After
being autoclaved, sterile solutions of ticarcillin sodium salt
(100 mg) and polymyxin B sulfate (300,000 U) were added
per liter of medium. All inorganic chemicals used were
reagent grade. Proteose peptone no. 3, bile salts (Oxgall),
and agar were purchased from Difco Laboratories, Detroit,
Mich. Polymyxin B sulfate and pyruvic acid sodium salt
were purchased from Sigma Chemical Co., St. Louis, Mo.
Ticarcillin was a gift from Beecham Laboratories, Bristol,
Tenn.
Isolates used in growth studies. Fifty strains of P. cepacia
isolated from CF patients at St. Christopher's Hospital for
Children (SCHC), Philadelphia, Pa., were used in growth
studies. The identity of all 50 strains as P. cepacia was
confirmed by the Hospital Infection Program, Centers for
Disease Control, Atlanta, Ga. The P. aeruginosa and S.
aureus strains used in these studies were also isolated from
CF patients at SCHC. All other organisms (see Table 2) used
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TABLE 1. Comparison of growth of 50 isolates of P. cepacia on
PC medium, MacConkey agar, and 5% sheep blood agar after 48 h
of incubation
Growth condition and results No. of isolates
PC medium vs MacConkey agar
Superior on PC medium .......... .............. 38
Superior on MacConkey agar ........ ........... O
Similar ...................................... 12
PC Medium vs 5% sheep blood agar
Superior on PC medium .......... .............. O
Superior on blood agar ........... .............. 8
Similar ...................................... 42
in growth studies were fresh clinical isolates, identified by
standard laboratory techniques, from patients at SCHC or
North Carolina Memorial Hospital, Chapel Hill, N.C.
Growth studies. Growth studies were performed by inocu-
lating the test organisms into 3 ml of Trypticase soy broth
(BBL Microbiology Systems, Cockeysville, Md.) and incu-
bating them overnight at 35°C. These cultures were then
adjusted to a turbidity equal to a McFarland standard of 0.5,
and each isolate was inoculated with a sterile cotton swab
onto a quadrant of a PC medium plate, a MacConkey agar
plate, and, when S. aureus was tested, a 5% sheep blood
agar plate. The plates were incubated at 35°C and examined
daily for the presence or absence of growth. When growth of
P. cepacia was being compared on PC medium, MacConkey
agar, and 5% sheep blood agar, the relative abundance of
growth was recorded for each medium on each of 3 days.
Six P. cepacia strains were chosen at random for the
comparison of quantitative recovery of this organism on PC
medium, MacConkey agar, and 5% sheep blood agar. These
strains were grown overnight in Trypticase soy broth and
diluted 1:10,000 in saline to make a stock suspension. This
stock suspension was diluted 1:10, 1:100, and 1:1,000 in
saline, and 0.1 ml of the stock suspension and each dilution
was plated onto duplicate plates of each medium. After 48 h
of incubation at 35°C, each plate was counted, and the
number of organisms for each strain recovered on each type
of medium was recorded.
Culture of clinical specimens. Respiratory secretions, pri-
marily sputa, deep pharyngeal swabs, and bronchial wash-
ings, were cultured from patients identified by physicians or
by patient registry at two CF centers as having CF. At
SCHC, the cultures were made with PC medium, 5% sheep
blood agar, chocolate agar, mannitol salt agar (Difco), and
MacConkey agar. Cultures at North Carolina Memorial
Hospital were made on the same media as at SCHC, except
that 5% horse blood agar and colistin-nalixidic acid agar
were substituted for chocolate agar and sheep blood agar.
All plates were incubated at 35°C for 72 h and examined daily
for the presence ofP. cepacia and other potential respiratory
pathogens. P. cepacia was identified by the following cri-
teria: colonial morphology, disk diffusion susceptibility test-
ing, and (at SCHC) the Uni-N/F Tek (Flow Laboratories,
Inc., McLean, Va.) or (at North Carolina Memorial Hospi-
tal) conventional biochemical testing (5). All other potential
pathogens were identified by standard techniques (9).
RESULTS
Preliminary studies. Studies were done to modify the
holding medium formulation of DeCicco to develop an
isolation medium for the recovery of P. cepacia. Certain
additions to the medium were found to be necessary. An
amino acid source (0.1% proteose peptone no. 3) was
required for the growth of some of the P. cepacia isolates.
Experiments were also done to examine different selective
agents. The addition of 0.15% bile salts and either 100 or 300
U of polymyxin B per ml allowed similar growth of 10 P.
cepacia isolates when compared with media without these
components. Because of this observation, 10 clinical speci-
mens from CF patients were cultured on the holding medium
containing 0.1% proteose peptone no. 3, 0.15% bile salts,
and 300 U of polymyxin B per ml to assess its selectivity.
These experiments showed that S. aureus, mucoid and
rough strains of P. aeruginosa, Proteus mirabilis, yeast, and
mold, as well as P. cepacia, grew on this medium. Because
of these findings, 100 p.g of ticarcillin per ml and 0.0001%
crystal violet were added to the medium, the former to
inhibit gram-negative organisms and the latter to inhibit
gram-positive organisms.
Growth and selectivity studies. Experiments were per-
formed which compared the growth of 50 clinical isolates of
P. cepacia on MacConkey and 5% sheep blood agar and on
PC medium, which contained 300 U of polymyxin B per ml,
100 ,ug of ticarcillin per ml, 0.15% bile salts, and 0.0001%
crystal violet. Growth on PC medium was equal or superior
to growth on MacConkey agar after 48 h of incubation (Table
1). Comparative growth on 5% sheep blood agar and PC
medium showed that most isolates (84%) grew equally well
on the two media. In addition, all 50 P. cepacia isolates grew
on PC medium within 48 h.
Quantitative studies to compare the recovery of six P.
cepacia strains on these three media were performed by
quantitatively culturing a 1:10,000 dilution of an overnight
broth culture of these strains. Sheep blood was the most
sensitive, with an average recovery for these six strains of
1.2 x 104 CFU/ml. PC medium was nearly as sensitive, with
an average recovery of 9.1 x 103 CFU/ml, and MacConkey
agar was the least sensitive, with an average recovery of 6.1
x 103 CFU/ml.
To assess the selective nature of this medium, 120 isolates
of various gram-negative bacilli and 4 isolates of S. aureus
were examined for their ability to grow on PC medium
(Table 2). The choice of gram-negative bacilli for study was
based on the likelihood of recovery from sputa of CF
patients (1). None of the four strains of S. aureus grew on
this medium. Of 120 gram-negative bacillus isolates, 12 grew
on PC medium, and all grew on MacConkey agar. Of the
organisms tested, strains of Klebsiella pneumoniae were
able to grow most frequently on PC medium. All 12 non-P.
cepacia isolates which grew on PC medium did poorly when
compared with their growth on MacConkey agar. Because of
TABLE 2. Comparison of growth of gram-negative rods on PC
medium and MacConkey agar after 48 h of incubation
Growth detected on:
Organism (no. of isolates)
PC medium MacConkey agar
Achromobacter sp. (10) 2 10
Acinetobacter sp. (10) 0 10
Enterobacter sp. (4) 0 4
E. coli (6) 0 6
Klebsiella sp. (13) 6 13
Proteus sp. (10) 2 10
P. aeruginosa (43) 1 43
Pseudomonas maltophilia (10) 1 10
Serratia sp. (4) 0 4
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TABLE 3. Comparative recovery of S. aureus, P. aeruginosa,
and P. cepacia from 169 CF patients at 2 CF centers
Organism
No. positive/total ata:
Center 1 Center 2
S. aureus 61/126 20/43
P. aeruginosa 73/126 31/43
P. cepacia 34/126 1/43
a Number of patients positive for specific organism/number of patients
cultured.
the ability of PC medium to support the growth of all P.
cepacia isolates tested and its ability to inhibit the growth of
over 90% of isolates likely to be encountered in respiratory
secretions of CF patients, PC medium was examined to
determine whether it could be used as a primary isolation
medium to enhance the recovery of P. cepacia from respira-
tory cultures from CF patients.
Clinical studies. Respiratory secretions from 169 CF pa-
tients at two CF centers were examined for the presence of
potential respiratory tract pathogens, with special emphasis
on the detection of P. cepacia. P. cepacia was present in CF
patients at both centers (Table 3). The recovery rate at
center 1 (27%) was significantly higher than that at center 2
(2%). The recovery of S. aureus (48 and 47%, respectively)
and P. aeruginosa (58 and 72%, respectively) at the two
centers, on the other hand, was similar.
When recovery of P. cepacia on PC medium was com-
pared with that on MacConkey agar, PC medium was clearly
superior (Table 4). Of the 35 isolates of P. cepacia re-
covered, 14 were found only on PC medium. This was, in
part, because in cultures from seven patients there was
confluent growth of highly mucoid strains of P. aeruginosa
on MacConkey agar which probably obscured or inhibited
the growth of P. cepacia. In isolates from 18 patients, the
growth of P. cepacia was superior on PC medium; three
isolates showed similar growth on the two media. No iso-
lates were found only on MacConkey agar, nor did any
isolate grow better on MacConkey agar.
The ability of PC medium to inhibit the growth of other
potential pathogens was also examined. Of 221 potential
pathogens, only 6 grew on PC medium (Table 5). These
included two ticarcillin-resistant P. aeruginosa isolates, two
mold isolates, an isolate of Serratia sp., and one yeast. No
organisms which would be considered normal respiratory
flora, such as diphtheroids, saprophytic Neisseria sp.,
coagulase-negative staphylococci, and oral streptococci,
grew on PC medium (data not shown).
Description of the growth of P. cepacia on PC medium. PC
medium is dull yellow when uninoculated. After 24 h of
grown on PC medium, P. cepacia colonies are usually
TABLE 4. Comparative growth of the 35 isolates of P. cepacia
recovered from clinical specimens on PC medium and MacConkey
agar
Growth condition No. ofisolates
PC medium only.................... 14
Superior on PC medium .................... 18
MacConkey agar only ...... .............. 0
Superior on MacConkey agar ............O........
Similar .................... 3
TABLE 5. Recovery of other potential pathogens on PC medium
compared with recovery on all other media used for 169 CF
patients
No. of isolates recovered on:
Organism
PC medium All other media
Achromobacter sp. 0 2
Acinetobacter sp. 0 2
Beta-hemolytic streptococci 0 3
Citrobacter sp. 0 1
Enterobacter sp. 0 5
E. coli 0 5
Haemophilus influenza O 5
K. pneumoniae 0 1
P. aeruginosa 2 104
P. maltophilia 0 1
S. marcescens 1 2
S. aureus 0 81
Mold 2 7
Yeast 1 2
pinpoint, and in areas of heavy growth, the medium may
begin to turn pink. After 48 h of growth, isolated colonies are
1 to 2 mm in diameter. In areas of heavy growth, the agar is
usually hot pink. As the colonies age, they may become
slightly larger and have a purplish hue or remain grayish
white. The hot-pink color reaction is due to the alkaline end
products produced as a result of pyruvate metabolism by P.
cepacia, with phenol red being the pH indicator present in
the medium. Other organisms which grow on this medium
may also turn the medium pink; PC medium therefore cannot
be considered a truly differential medium.
DISCUSSION
Chronic respiratory disease is the primary contributing
factor in the premature death of patients with CF (13). S.
aureus and P. aeruginosa, especially mucoid colonial vari-
ants, have been well recognized as important pulmonary
pathogens in this process. With the advent of relatively
effective antimicrobial therapy to control these two patho-
gens, life expectancy in this patient population has risen
dramatically (13). Recently, P. cepacia has emerged as a
potentially important respiratory pathogen in at least three
large CF centers (6, 8, 12). One characteristic of P. cepacia
which has made its emergence particularly distressing has
been its resistance, in vitro and in vivo, to both conventional
and experimental antimicrobial therapy (7).
The role of P. cepacia in pulmonary disease remains
controversial. In cases in which it is recognized, the spec-
trum of disease can range from long-term colonization to
rapidly progressive (1 to 3 weeks) fatal illness. Unlike P.
aeruginosa, P. cepacia is relatively avirulent in animal
models (4, 11). Although isolates from CF patients have both
proteolytic and lipolytic activities, they produce neither
elastase nor toxins similar to P. aeruginosa toxin A, both of
which are postulated to be important virulence factors in
pulmonary disease in CF patients (10; P. H. Gilligan, W. H.
Yeung, D. Yucht, and D. Schidlow, Cystic Fibrosis Club
25:113, 1984).
To assess the role of P. cepacia in pulmonary disease of
CF patients, an isolation medium specific for it appears to be
essential. P. cepacia has been reported to be present in as
few as 1% to as many as 27% of CF patients, depending on
the reporting center (1). These may represent real differ-
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ences in the centers, as was shown in this study (with a
selective medium, 27% of the patients were positive for P.
cepacia in one center and 2% in the other), or differences in
the ability of different laboratories to recognize P. cepacia
among flora growing in isolates from the respiratory tract of
CF patients. A major concern when clinical specimens from
CF patients are examined for P. cepacia is its slow growth
on commonly used laboratory media when compared with
other organisms present in these specimens. Mucoid strains
of P. aeruginosa are of particular concern, as shown in this
study: 20% of the P. cepacia isolates were not recovered on
MacConkey agar in the presence of heavy growth of mucoid
strains ofP. aeruginosa. These isolates would not have been
detected by means other than PC medium. Overall, 40% of
the P. cepacia strains isolated in this study were found only
on PC medium. These data suggest that a selective medium
specific for P. cepacia isolation, such as PC medium, should
be used to obtain more accurate epidemiological information
concerning the role that P. cepacia plays in the pulmonary
deterioration seen in CF patients.
Two other selective media for the isolation of P. cepacia
have recently been described. One medium (M. J.
Muszynski, D. A. Pickett, and D. F. Welch, Program Abstr.
24th Intersci. Conf. Antimicrob. Agents Chemother., abstr.
no. 179, 1984), in which bacitracin and polymyxin B are used
as selective agents, and production of acid from lactose is
used as a differential test, has been shown to support the
growth of stock cultures of P. cepacia, which has been
recovered on this medium from sputa seeded with it. With
this medium, P. cepacia was not recovered from sputum
specimens obtained from 25 CF patients (D. Welch, personal
communication).
The other medium that was recently described (14) was
designed to recover P. cepacia from environmental sources.
With 9-chlora-9-(4-diethylaminophenyl)-10-phenylacridan
and polymyxin B as selective agents, it effectively inhibits
the growth of most organisms. However, Serratia
marcescens and P. cepacia grow equally well on this me-
dium. In addition, the efficacy of recovery of P. cepacia is
judged by using only environmental water specimens. It
would be difficult to extrapolate the utility of this medium for
isolation of P. cepacia from clinical specimens based on
studies with environmental water specimens.
The use of PC medium should enhance the recovery of P.
cepacia from respiratory secretions of CF patients. The
more reliable recovery of P. cepacia from CF patients
should aid in the evaluation of the role of this organism in
pulmonary disease in CF patients.
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